TRCT
TRIB

Tower Research Capital (TRC)’s Trinity Biotech TRIB Stock Holding History

Tower Research Capital (TRC)’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-27
Closed – – 4362
2019
Q3 		$0 Sell
27
-268
-91% -$2.33K ﹤0.01% 4514
2019
Q2 		$2K Sell
295
-2,476
-89% -$29.4K ﹤0.01% 3318
2019
Q1 		$39K Buy
2,771
+420
+18% +$5.77K ﹤0.01% 1895
2018
Q4 		$27K Sell
2,351
-577
-20% -$8.91K ﹤0.01% 1712
2018
Q3 		$59K Buy
2,928
+1,100
+60% +$23.9K ﹤0.01% 1666
2018
Q2 		$46K Sell
1,828
-159
-8% -$3.83K ﹤0.01% 1897
2018
Q1 		$51K Buy
1,987
+168
+9% +$4.58K ﹤0.01% 1667
2017
Q4 		$46K Sell
1,819
-643
-26% -$16.6K 0.01% 1395
2017
Q3 		$69K Buy
2,462
+2,034
+475% +$56.7K 0.01% 1695
2017
Q2 		$13K Buy
428
+394
+1,159% +$11.2K ﹤0.01% 1465
2017
Q1 		$1K Sell
34
-35
-51% -$1.09K ﹤0.01% 2854
2016
Q4 		$2K Sell
69
-330
-83% -$11.4K ﹤0.01% 3465
2016
Q3 		$26K Buy
399
+339
+565% +$21.1K ﹤0.01% 1469
2016
Q2 		$3K Sell
60
-209
-78% -$11.8K ﹤0.01% 3745
2016
Q1 		$16K Buy
269
+229
+573% +$12.2K ﹤0.01% 1521
2015
Q4 		$2K Buy
40
+23
+135% +$1.36K ﹤0.01% 3810
2015
Q3 		$1K Sell
17
-811
-98% -$65.3K ﹤0.01% 3680
2015
Q2 		$75K Buy
+828
New +$71.7K 0.01% 1065
2014
Q4 		– Sell
-41
Closed -$4K – 4688
2014
Q3 		$4K Sell
41
-712
-95% -$77.1K ﹤0.01% 3461
2014
Q2 		$87K Buy
+753
New +$89.2K 0.01% 980
2014
Q1 		– Sell
-299
Closed -$38K – 4929
2013
Q4 		$38K Buy
299
+232
+346% +$27.8K 0.01% 1635
2013
Q3 		$7K Sell
67
-48
-42% -$4.68K ﹤0.01% 3462
2013
Q2 		$10K Buy
+115
New +$9.54K ﹤0.01% 2382

Other funds holding TRIB

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Tower Research Capital (TRC)'s TRIB Position: Q4 2019 in Review

Tower Research Capital (TRC) sold out of Trinity Biotech (TRIB) in Q4 2019, closing a stake of 27 shares.

Tower Research Capital (TRC) first reported a position in TRIB in Q2 2013 and held it in 23 quarters. The position peaked at $87K in Q2 2014. 26 funds tracked by Wall St. Rank hold TRIB as of Q4 2019.

  • Tower Research Capital (TRC) reported no remaining Trinity Biotech position as of Q4 2019 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 27 Trinity Biotech shares in Q4 2019.
  • Tower Research Capital (TRC) first reported a position in Trinity Biotech in Q2 2013 and held it in 23 quarters.
  • Tower Research Capital (TRC)'s Trinity Biotech position peaked at $87K in Q2 2014.
  • 26 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2019.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.